NanoViricides Story

<div class='circular--portrait' style='background:#9CBEFD;color: #ffffff;font-size:4em;'>NI</div>
NNVC -- USA Stock  

USD 3.90  0.02  0.52%

NanoViricides Stock News module provides quick insight into current market opportunities from investing in NanoViricides Inc NEW. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use NanoViricides NEW stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Additionally, see NanoViricides Inc Hype Analysis, NanoViricides Inc Correlation and NanoViricides Inc Performance.

Search Today's Stock News

 
Refresh
NanoViricides Inc stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of NanoViricides daily returns and investor perception about the current pice of NanoViricides Inc NEW as well as its diversification or hedging effects on your existing portfolios.
Sale by Theracour Pharma Inc of 10000 shares of NanoViricides Inc
Filed transaction by Nanoviricides Inc executive. General open market or private sale of non-derivative or derivative security

NanoViricides Inc NEW insider trading alert for sale of common stock by Theracour Pharma Inc, the corporate stakeholder, on 17th of April 2020. This event was filed by Nanoviricides Inc with SEC on 2009-07-17. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   

Beta

Beta Comparative Analysis

NanoViricides Inc is currently under evaluation in beta category among related companies. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it will be expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Peers

NanoViricides Inc Related Equities

DYAIDYADIC INTERNATIONAL INC   4.44   
0%
69.0%
DMACDiaMedica Therapeutics   2.38   
0%
37.0%
DRNADicerna Pharmaceuticals   1.44   
0%
22.0%
DVAXDynavax Technologies Corporation   0.96   
0%
14.0%
EQEquillium   0.52   
0%
8.0%
DNLIDenali Therapeutics   0.53   
8.0%
0%
EDITEditas Medicine   1.53   
23.0%
0%
DTILPrecision BioSciences   1.86   
29.0%
0%
EARSAuris Medical Holding   3.33   
51.0%
0%
NKNantKwest   6.41   
100.0%
0%
Additionally, see NanoViricides Inc Hype Analysis, NanoViricides Inc Correlation and NanoViricides Inc Performance. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .